What did MPS Ltd pay for Unbound Medicine?

MPS Ltd acquired Unbound Medicine for $16.5M in 2026, equivalent to 1.90x revenue. Target revenue was approximately $8.9M.

What does Unbound Medicine do?

Unbound Medicine is a healthcare it business.

What multiple did MPS Ltd pay for Unbound Medicine?

1.90x revenue, based on disclosed deal value of $16.5M and disclosed financials.

M&A TRANSACTION · 2026

Unbound Medicine acquired by MPS Ltd

$16.5M· 1.90x revenue

Target

Unbound Medicine

Acquirer

MPS Ltd

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$8.9M

EBITDA

—

Deal Value

$16.5M

EV/EBITDA

—

Context

This $16.5M acquisition of Unbound Medicine by MPS Ltd sits in the healthcare it sub-vertical. MPS Ltd is acquiring as a strategic buyer; see how strategic acquirers typically price healthcare it businesses on our Healthcare It strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own healthcare it

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Unbound Medicine acquisition.

Citation: ExitValue.ai. (2026). Unbound Medicine acquired by MPS Ltd. https://exitvalue.ai/deals/unbound-medicine-acquired-by-mps-ltd-hc-2026-0001